Detalles de la búsqueda
1.
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Cancer Immunol Immunother
; 73(3): 45, 2024 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349430
2.
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Cytotherapy
; 26(4): 318-324, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340107
3.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Br J Haematol
; 195(3): 405-412, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34500492
4.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32649981
5.
Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
Transpl Infect Dis
; 22(2): e13242, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895492
6.
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Blood
; 140(2): 152-156, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537186
7.
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Haematologica
; 109(2): 682-688, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675514
8.
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib.
Acta Haematol
; 141(2): 107-110, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30695783
9.
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.
Clin Infect Dis
; 63(1): 41-7, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27169477
10.
Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma.
Br J Haematol
; 192(1): 212-216, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33169845
11.
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Blood
; 121(15): 2864-74, 2013 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23426943
12.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
; 122(25): 4129-39, 2013 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24055823
13.
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.
Biol Blood Marrow Transplant
; 20(1): 4-13, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24018392
14.
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
; 119(12): 2956-9, 2012 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22289893
15.
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab.
Am J Hematol
; 94(8): E216-E219, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31120638
16.
Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss.
Am J Hematol
; 94(10): E273-E275, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342556
17.
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.
Biol Blood Marrow Transplant
; 19(12): 1661-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24018393
18.
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation.
Biol Blood Marrow Transplant
; 19(11): 1537-45, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24018395
19.
Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 19(10): 1509-13, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23948062
20.
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
Br J Ophthalmol
; 107(7): 901-905, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35144919